MedPath

Feasibility and Efficacy of Remotely Monitored Home-based Listening to Preferred Music for Pain in Older Adults With Low Back Pain

Not Applicable
Completed
Conditions
Lower Back Pain
Interventions
Other: Music Listening
Registration Number
NCT04644757
Lead Sponsor
The University of Texas Health Science Center, Houston
Brief Summary

The purpose of this study is to examine the feasibility and acceptability of listening to 20 minutes of preferred style of music twice-daily for 4 consecutive days on pain among 20 community-dwelling older adults with lower back pain (LBP)

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • self-report of Lower back pain (LBP)
  • LBP in the past 3 months with an average rating of at least 30 on a 0 - 100 NRS for pain
  • intact cognition
  • no plans to change their pain medication regimens during the study time
  • can read and understand English
  • can travel to the study center
  • agree to sign an informed consent
Exclusion Criteria
  • deaf or have severe hearing loss
  • pregnant or lactating
  • have an implantable pain-reducing device
  • history of hospitalization within the preceding year for psychiatric illness
  • diagnosis of Raynaud's disease
  • have a functional limitation that requires the use of an ambulatory aid such as a cane, walker, or wheelchair
  • history of brain surgery, brain tumor, or stroke
  • severe depression (PROMIS Depression T-score ≥ 70) (Kroenke et al., 2020)
  • severe anxiety (PROMIS Anxiety ≥ 70) (American Psychiatric Association, 2013)
  • Mini-Mental State Examination score less than 24 (Creavin, Wisniewski, Noel-Storr, et al., 2016)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
TreatmentMusic Listening-
Primary Outcome Measures
NameTimeMethod
Adherence rate6 months from start of study

Assessed as number completing all measures divided by number enrolled

Enrollment rate: Assessed as number enrolled or number who met inclusion criteria6 months from start of study
Attrition rate6 months from start of study

Assessed as number not completing the study divided by number enrolled at baseline

Treatment acceptability: Measured by the treatment acceptability and preference scale(TAPBaseline

Assess perceived acceptability of treatment using TAP in four categories of appropriateness, effectiveness, suitability, and willingness to adhere on a scale ranging from 0 (not at all) to 4 (very much).

Treatment acceptability: Measured by the treatment acceptability and preference scale(TAP)5 days after baseline(1 day after completion of intervention)

Assess perceived acceptability of treatment using TAP in four categories of appropriateness, effectiveness, suitability, and willingness to adhere on a scale ranging from 0 (not at all) to 4 (very much).

Secondary Outcome Measures
NameTimeMethod
Anxiety as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety Short FormBaseline

The PROMIS Anxiety Short Form has 8 items with each item on the measure being rated on a 5-point scale (1-5) , a higher number indicating a worse outcome

Depression as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS) Depression Short FormBaseline

The PROMIS Depression Short Form has 8 items with each item on the measure being rated on a 5-point scale (1-5) , a higher number indicating a worse outcome

Pain as measured by the numerical rating scale (NRS)post intervention (day 5)

Self-reported mean clinical pain intensity defined as the average pain intensity experienced in the past 24 hours will be measured using the 101-point NRS where 0 means no pain and 100 means worst imaginable pain.

Change in brain activation in the motor and somatosensory cortex as measured by functional near-infrared spectroscopy (fNIRS)Baseline and post-intervention (Day 5)

Pain-related measure of hemodynamic response function will be measured during pressure pain stimulation using a continuous-wave, multichannel fNIRS imaging system (LIGHTNIRS, Shimadzu, Kyoto, Japan) with three semiconductor lasers at 780, 805, and 830 nm.

Change in conditioned pain modulation (CPM)Baseline and post-intervention (Day 5)

Conditioned pain modulation will measure the difference in pressure pain threshold before and after a painful "conditioning stimulus" is applied to test central pain inhibition. The conditioning stimulus will involve the immersion of one hand in a cold-water bath. The pressure pain tolerance will be evaluated following a conditioning stimulus condition

Change in heart rate variability (HRV)Baseline and post-intervention (Day 5)

Heart rate variability will be assessed as an indicates the sympathetic nervous system status using lead II arrangement with an MP160 Data Acquisition Systems (Biopac Systems, Inc., Goleta, CA, U.S.A.).

Trial Locations

Locations (1)

The University of Texas Health Science Center at Houston

🇺🇸

Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath